... LifeSci Communications 646-970-4682 veames@lifescicomms.com. Stock Quote. Nasdaq:CDTX$0.68▽ $-0.04-5.68%. Price. $0.68. Change(%). ▽ $-0.04-5.68%. Volume.
... Investors · Investor Overview · Press Releases · Events + Presentations · Company Information · Stock Information · Analyst Coverage · SEC Filings · Corporate ...
Cidara Therapeutics (CDTX) Investor Presentation - Slideshow · SA TranscriptsFri, Dec. 02, 2022. Cidara Therapeutics (CDTX) Investor Presentation - Slideshow.
Missing: relations | Show results with:relations
2 days ago · The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative ...
Missing: relations | Show results with:relations
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more. Before you Invest, Investor.gov. Get ...
Get the latest insights on Cidara Therapeutics, Inc. Common Stock (CDTX) with press releases and corporate news to help you in your trading and investing ...
People also ask
What does Cidara Therapeutics do?
Who makes Rezafungin?
Is cidara therapeutics approved by the FDA?
What is CD388?
(US:CDTX) has 69 institutional owners and shareholders ... Investor Shares, Renaissance Technologies Llc ... relation to this website or the information and ...